Speaker: Ursula Theuretzbacher, Center for Anti-Infective Agents, Austria
Moderator: Laura Piddock, Director Scientific Affairs, GARDP
In this webinar, Ursula Theuretzbacher discussed why small companies and academic labs are currently the main drivers of antibiotic R&D and what challenges they face. Topics discussed included:
- Mainly small companies are active in antibacterial drug R&D and pursue a variety of approaches
- Main challenges of various antibacterial R&D approaches
- What to learn from industry and funders
- How to avoid the most common mistakes in grant proposal writing
* This presentation was part of a Meet-the-experts session at the ASM Microbe Conference 2019, jointly organized by GARDP, CARB-X, and REPAIR Impact Fund. *
This live webinar including interactive Q&A session was broadcast on 18 July 2019.
If you have questions or comments, please let us know: revive@gardp.org.